Navigation Links
Vaccine Leaders All Over the World Talking About China Vaccine Opportunities at VacChina 2010 -- the No.1 China Focused Vaccine Partnering Forum

SHANGHAI, Oct. 17 /PRNewswire-Asia/ -- At the end of 2009, the vaccine industry raised so much concern worldwide that the headlines of the business media were occupied by various kinds of news about vaccine enterprises. For example, Sinovac Biotech Co., Ltd. successfully landed on the Nasdaq, then Simcere, a pharmaceutical company based in Jiangsu Province, listed on the NYSE, announced a 50.8% stake in Ealong Biotech and took control of the latter, and finally Novartis, the world-famous pharmaceutical company headquartered in Switzerland, acquired an 85.0% equity in Tianyuan Bio-Pharmaceutical, a vaccine producer, for RMB850M. These deals indicate that the investors and foreign pharmaceutical giants have not slowed down their pace to enter China's vaccine market, even in the face of this economic recession.

Hosted by Global Leaders Institute, world vaccine industry leaders convened at VacChina 2010 on Sept 15 and 16 in Shanghai. The two-day executive summit featured over 30 speakers and attendances from top executives including Junfang Gao, GM of Changchun Changsheng Life Science and An Kang, Chairman of the Board from Hualan Bio to share views on the latest China vaccine industry regulatory environment, research capabilities, market trends, and status of technology applications etc. Well attended by over 200 attendees from vaccine producers home and abroad including 6 main institutes of biological products in China and top China vaccine manufacturers like Zhejiang Tianyuan, Chengda Bio, Shanghai United Cell, Wison Bio, Walvax, Tasly and Innovax gathered under the same roof to look for partnering opportunities, VacChina 2010 was undoubtedly the most high end vaccine meeting held in China this year. Besides, thanks to over 20 corporate sponsors showcasing their state of the art vaccine R&D technologies at the event, VacChina 2010 is also a premier platform for various technology providers presenting their latest advancements in vaccine bioreactor, cell culture, single use and purification.

As a top gold sponsor in the grand event, Pall Life Sciences introduced ground-breaking technologies and expanded service offerings to help manufacturers improve their vaccine products and processes. These technologies include Single use system, disposable depth filter with the Stax system, membrane chromatography-Mustang, various advance designed sterile filters and the cutting-edge integrity test instrument -- Flowstar IV.  All of these could be used as total solution to be incorporated into vaccine production, the benefits to the manufacturers are to reduce the contaminant as low as possible, eliminate the cross contamination by containment and save the production cost as much as possible, and thus all these benefits will improve the vaccine's quality and safety and allow people in the world to live a better life.

About Global Leaders Institute

Global Leaders Institute is the producer and organizer of top-level business events. We focus on the development and operation of the strategic, market leading business conference. We focus on the specialty spirit and professional attainment. We focus on value creation for our client. We provide 60 annual conferences across energy, finance, transportation, life science, real estate, telecom and media, etc. each year.

SOURCE Global Leaders Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. IDRI Develops Novel Tuberculosis Vaccine, New Study in Science Reports
2. Consumer Reports Flu Poll: Approximately Three Out of 10 Health Care Workers Living in a Bubble, Not Getting Flu Vaccine
3. Vaccine and Medication Safety are Parents Top Research Priorities
4. BiondVax Begins Phase IIa Study for Universal Flu Vaccine
5. Sanofi Pasteur and U.S. Department of Health and Human Services Enter Into Agreement for Pandemic Vaccine Preparedness
6. GenVec Receives Second-Year Funding From SAIC for HIV and Influenza Vaccine Development
7. Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports
8. immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio
9. Ukrainian Government Unit Sues in U.S. - Alleges Corrupt Scheme in Vaccine Purchases
10. LigoCyte Pharmaceuticals Initiates First Clinical Trial for Bivalent Intramuscular Norovirus Vaccine
11. Generex Announces Presentations of Novel Vaccine Strategies
Post Your Comments:
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
Breaking Medicine Technology:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):